Oncobit enabling personalized cancer care by developing precise and highly sensitive diagnostic and monitoring tests.
Oncobit has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in November 2024.
Oncobit's investors include Venture Kick, Kickfund, GF Group Holding, AVANTECA Partners.
Oncobit is headquartered in Zurich, Switzerland.
Oncobit enabling personalized cancer care by developing precise and highly sensitive diagnostic and monitoring tests.
Oncobit is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncobit — Funding & Investors." VCBacked, November 20, 2024, https://www.vcbacked.co/company/oncobit. Accessed July 20, 2026.
VCBacked. (2024). Oncobit — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/oncobit
{{cite web |title=Oncobit — Funding & Investors |url=https://www.vcbacked.co/company/oncobit |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated